Table 2.
Univariable and multivariable predictors of MACE
| Variables | Univariable | Multivariable | ||
|---|---|---|---|---|
| Hazard Ratio (95 % CI) |
P Value | Hazard Ratio (95 % CI) |
P Value | |
| Age | 1.016 (0.999–1.033) | 0.0585 | 0.985 (0.958–1.013) | 0.286 |
| Male | 1.014 (0.638–1.612) | 0.9531 | - | - |
| Diabetes | 1.693 (1.058–2.713) | 0.0309 | 0.863 (0.428–1.740) | 0.680 |
| Hyperlipidemia | 1.326 (0.825–2.131) | 0.2397 | - | - |
| Smoking | 0.998 (0.555–1.795) | 0.9953 | - | - |
| Hypertension | 2.482 (1.189–5.181) | 0.0066 | 2.355 (0.820–6.766) | 0.112 |
| NYHA class | 0.810 (0.618–1.060) | 0.1080 | 0.853 (0.519–1.403) | 0.532 |
| LVEF | 1.001 (0.985–1.017) | 0.9234 | - | - |
| LGE present | 1.263 (0.757–2.110) | 0.3794 | - | - |
| LV mass | 1.009 (1.002–1.017) | 0.0211 | 1.008 (1.000–1.015) | 0.044 |
| Lateral MAPSEa | 2.228 (1.051–4.679) | 0.0331 | 4.384 (1.257–15.271) | 0.020 |
| Septal MAPSEa | 1.585 (0.682–3.715) | 0.2865 | - | - |
LGE late gadolinium enhancement, LV left ventricular, LVEF left ventricular ejection fraction, MAPSE Mitral Annular Plane Systolic Excursion, NYHA New York Hear Association. aper cm decrease